File(s) not publicly available
Benzodiazepines: risks and benefits. A reconsideration
journal contribution
posted on 2023-06-08, 22:03 authored by David S Baldwin, Katherine Aitchison, Alan Bateson, H Valerie Curran, Simon Davies, Brian Leonard, David J Nutt, Dai Stephens, Sue WilsonOver the last decade there have been further developments in our knowledge of the risks and benefits of benzodiazepines, and of the risks and benefits of alternatives to benzodiazepines. Representatives drawn from the Psychopharmacology Special Interest Group of the Royal College of Psychiatrists and the British Association for Psychopharmacology together examined these developments, and have provided this joint statement with recommendations for clinical practice. The working group was mindful of widespread concerns about benzodiazepines and related anxiolytic and hypnotic drugs. The group believes that whenever benzodiazepines are prescribed, the potential for dependence or other harmful effects must be considered. However, the group also believes that the risks of dependence associated with long-term use should be balanced against the benefits that in many cases follow from the short or intermittent use of benzodiazepines and the risk of the underlying conditions for which treatment is being provided.
History
Publication status
- Published
Journal
FOCUSISSN
1541-4094Publisher
American Psychiatric PublishingExternal DOI
Issue
2Volume
12Page range
229-234Department affiliated with
- Psychology Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2015-08-06Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC